The creation of the joint company of RDIF and Medscan Group
MC "DTI" acted as a consultant to the deal
April 24, 2020 - The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, announces the launch of a project to diagnose and detect pneumonia, including that caused by the SARS-COV-2 coronavirus, using CT scans combined with Russian-UAE artificial intelligence (AI) technology developed in partnership between Group 42 (G42), UAE’s leading technology company, RDIF and Medscan Group, Russian network of medical centres.
The Russian-UAE AI technology is more than 96% accurate with a high sensitivity to detect signatures of pneumonia. It has been tested on numerous patients with suspected SARS-COV-2 coronavirus in Hubei Province, China. The system enables automatic pneumonia detection within 1-2 minutes after taking the picture. The analysis of the CT scans will be processed exclusively on computer servers in Russia in accordance with national legislation.
“Highly accurate and timely diagnosis of coronavirus infection is one of the keys to a successful fight against the virus. The Russian-UAE AI technology allows quick and very accurate determination of the patient’s status, which significantly increases the efficiency of the diagnosis and treatment of coronavirus. Medscan’s experience in introducing advanced diagnostic systems and developing modern approaches to managing health risks will help reduce the negative impact of coronavirus infection in Russia.”
“Medscan Group has always considered the introduction of advanced international technologies in Russia as a priority. We are confident Russia can make full use of international experience thanks to RDIF’s wide network of partnerships, supplemented with domestic developments. Our joint efforts with RDIF will ultimately enable Russian doctors to provide patients with high-quality medical care.”
